TG Therapeutics, Inc. (BIT:1TGTX)

TG Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	-	179.89	92.93	102.3	298.89	553.44
Short-Term Investments	-	131.11	124.58	59.37	15.88	51.99
Cash & Short-Term Investments	251.87	311	217.51	161.68	314.76	605.43
Cash Growth	-26.15%	42.98%	34.53%	-48.63%	-48.01%	331.11%
Accounts Receivable	-	129.19	51.09	-	1.39	-
Receivables	-	129.19	51.09	-	1.39	-
Inventory	-	110.46	39.82	-	-	-
Other Current Assets	-	15.72	9.52	6.6	14.81	6.31
Total Current Assets	-	566.36	317.94	168.27	330.97	611.74
Property, Plant & Equipment	-	7.15	8.05	9.2	9.23	9.79
Long-Term Investments	-	0.81	-	12.4	35.53	-
Goodwill	-	-	-	0.8	0.8	0.8
Long-Term Deferred Charges	-	-	-	1.63	1.84	2.05
Other Long-Term Assets	-	3.37	3.59	1.27	1.26	1.26
Total Assets	-	577.69	329.59	193.57	379.63	625.64
Accounts Payable	-	26.3	29.27	42.02	50.89	37.01
Accrued Expenses	-	15.19	12.17	8.43	10.17	8.46
Current Portion of Long-Term Debt	-	0.66	0.36	0.24	1.34	23.12
Current Portion of Leases	-	1.16	1.45	1.58	1.44	1.67
Current Unearned Revenue	-	11.41	0.15	-	0.2	0.2
Other Current Liabilities	-	35.97	10.32	0.93	1.35	17.1
Total Current Liabilities	-	90.68	53.72	53.2	65.38	87.55
Long-Term Debt	-	244.43	100.12	71.14	66.79	7.72
Long-Term Leases	-	8.13	9.23	10.34	9.85	10.41
Long-Term Unearned Revenue	-	12.09	6.02	0.31	0.46	0.61
Total Liabilities	-	355.33	169.09	134.99	142.48	106.29
Common Stock	-	0.16	0.15	0.15	0.14	0.14
Additional Paid-In Capital	-	1,760	1,713	1,586	1,566	1,500
Retained Earnings	-	-1,529	-1,553	-1,527	-1,329	-980.6
Treasury Stock	-	-8.99	-0.23	-0.23	-0.23	-0.23
Shareholders' Equity	276.43	222.36	160.5	58.59	237.15	519.35
Total Liabilities & Equity	-	577.69	329.59	193.57	379.63	625.64
Total Debt	254.53	254.38	111.15	83.3	79.41	42.91
Net Cash (Debt)	-2.66	56.62	106.36	78.38	235.36	562.51
Net Cash Growth	-	-46.76%	35.70%	-66.70%	-58.16%	465.67%
Net Cash Per Share	-0.02	0.35	0.72	0.58	1.78	4.88
Filing Date Shares Outstanding	145.42	145.23	144.78	137.63	130.79	129.8
Total Common Shares Outstanding	145.42	143.99	141.79	137.65	131.22	129.79
Working Capital	-	475.68	264.22	115.07	265.58	524.19
Book Value Per Share	1.90	1.54	1.13	0.43	1.81	4.00
Tangible Book Value	276.43	222.36	160.5	57.79	236.35	518.55
Tangible Book Value Per Share	1.90	1.54	1.13	0.42	1.80	4.00

Source: S&P Global Market Intelligence. Standard template. Financial Sources.